CLDN7-C17ORF61 Fusion FISH Probe
The CLDN7-C17ORF61 Fusion FISH Probe is used to confirm a fusion of the CLDN7 and C17ORF61 genes. The fusion of the CLDN7 and C17ORF61 genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CLDN7-C17ORF61-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CLDN7-C17ORF61-20-AQAQ | 20 (40 μL) | 200 μL |
|
CLDN7 Gene Summary
This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets, and also play critical roles in maintaining cell polarity and signal transductions. Differential expression of this gene has been observed in different types of malignancies, including breast cancer, ovarian cancer, hepatocellular carcinomas, urinary tumors, prostate cancer, lung cancer, head and neck cancers, thyroid carcinomas, etc.. Alternatively spliced transcript variants encoding different isoforms have been found.[provided by RefSeq, May 2010]
Gene Name: Claudin 7
Chromosome: CHR17: 7163221 -7166512
Locus: 17p13.1
Gene Diseases
The CLDN7 C17ORF61 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|